Charles River Q4 2025 Adj. EPS $2.39 Beats $2.34 Estimate, Sales $994.227M Beat $986.996M Estimate
Charles River Laboratories International, Inc. +2.21%
Charles River Laboratories International, Inc. CRL | 183.28 | +2.21% |
Charles River Q4 2025 Adj. EPS $2.39 Beats $2.34 Estimate, Sales $994.227M Beat $986.996M Estimate
